Allogeneic MSC (AlloMSC)
NSFC30772014
Phase 2 mab active
Quick answer
Allogeneic MSC (AlloMSC) for Refractory Systemic Lupus Erythematosus is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Refractory Systemic Lupus Erythematosus
- Phase
- Phase 2
- Modality
- mab
- Status
- active